11 days ago
WVE
AnalystsWhitney IjemWhitney Ijem's Stock Forecasts
AnalystsWhitney Ijem
Sectors:
Industries:
Analyst Ranking
Top 6%
#268 out of 5223 analysts
Average Return
+25.05%
Win Rate
44%54 out of 122
Risk vs Reward
Poor
Good
Whitney Ijem's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcturus Therapeutics Holdings IncARCT | +606.98% | $12.03 | $85.05 | 2020-02-06 - 2021-02-05 | Strong Buy |
Palvella Therapeutics IncPVLA | +584.04% | $18.80 | $128.60 | 2025-02-25 - 2026-02-25 | Strong Buy |
Regulus Therapeutics IncRGLS | +482.48% | $1.37 | $7.98 | 2025-03-16 - 2025-04-30 | Strong Buy |
Palvella Therapeutics IncPVLA | +410.20% | $22.05 | $112.50 | 2025-05-15 - 2026-03-20 | Strong Buy |
Palvella Therapeutics IncPVLA | +333.32% | $19.00 | $82.33 | 2025-02-19 - 2026-02-19 | Strong Buy |
Whitney Ijem Analyst Color
Get additional color on Whitney Ijem's coverage of popular stocks
23 days ago
BMRN
a month ago
ALNY
2 months ago
WVE
2 months ago
BMRN
3 months ago
PVLA
3 months ago
RYTM
3 months ago
WVE
4 months ago
GUTS
4 months ago
PVLA
4 months ago
RYTM
5 months ago
PVLA
7 months ago
PVLA
7 months ago
TSHA
8 months ago
ALNY
8 months ago
RYTM
10 months ago
TSHA
10 months ago
TSHA
a year ago
TNYA
a year ago
SRPT
a year ago
VERV
a year ago
RYTM
2 years ago
RARE
2 years ago
ARCT
2 years ago
RGLS
Whitney Ijem's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ocugen IncOCGN | 1 | Strong Buy | $12.00 | +488.24% | Initiates Coverage On | 4 days ago |
Wave Life Sciences LtdWVE | 4 | Strong Buy | $52.00 | +342.18% | Maintains | 11 days ago |
Arcturus Therapeutics Holdings IncARCT | 6 | Strong Buy | $21.00 | +216.74% | Maintains | 16 days ago |
Passage Bio IncPASG | 8 | Strong Buy | $23.00 | +209.56% | Maintains | 17 days ago |
Intellia Therapeutics IncNTLA | 7 | Strong Buy | $48.00 | +273.83% | Maintains | 18 days ago |
Rhythm Pharmaceuticals IncRYTM | 10 | Strong Buy | $140.00 | +60.09% | Maintains | 19 days ago |
Neurogene IncNGNE | 1 | Strong Buy | $200.00 | +949.87% | Initiates Coverage On | 22 days ago |
Biomarin Pharmaceutical IncBMRN | 10 | Strong Buy | $104.00 | +92.13% | Maintains | 23 days ago |
Beam Therapeutics IncBEAM | 1 | Strong Buy | $74.00 | +200.45% | Initiates Coverage On | a month ago |
Ultragenyx Pharmaceutical IncRARE | 10 | Strong Buy | $79.00 | +297.58% | Maintains | a month ago |
Vertex Pharmaceuticals IncVRTX | 10 | Hold | $441.00 | -2.86% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 10 | Strong Buy | $429.00 | +37.43% | Maintains | a month ago |
Tenaya Therapeutics IncTNYA | 7 | Strong Buy | $5.00 | +565.78% | Maintains | 3 months ago |
Palvella Therapeutics IncPVLA | 8 | Strong Buy | $204.00 | +81.33% | Maintains | 3 months ago |
Fractyl Health IncGUTS | 2 | Strong Buy | $8.00 | +1,714.06% | Maintains | 4 months ago |
Generation Bio CoGBIO | 3 | Strong Buy | $10.00 | +87.27% | Maintains | 7 months ago |
Taysha Gene Therapies IncTSHA | 11 | Strong Buy | $14.00 | +218.18% | Maintains | 7 months ago |
Rocket Pharmaceuticals IncRCKT | 9 | Strong Buy | $10.00 | +141.55% | Maintains | 8 months ago |
Verve Therapeutics IncVERV | 6 | Hold | $13.00 | +16.80% | Downgrades | 9 months ago |
Regulus Therapeutics IncRGLS | 6 | Hold | $11.00 | +34.80% | Downgrades | a year ago |
Sarepta Therapeutics IncSRPT | 1 | Strong Buy | $150.00 | N/A | Maintains | a year ago |
Sigilon Therapeutics IncSGTX | 2 | Strong Buy | $30.00 | N/A | Maintains | 3 years ago |
Neubase Therapeutics IncNBSE | 1 | Strong Buy | $260.00 | N/A | Initiates Coverage On | 6 years ago |
Karyopharm Therapeutics IncKPTI | 4 | Strong Buy | $240.00 | N/A | Upgrades | 7 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.